In our present study, Ctgf was markedly overexpressed in all CKD groups, and Col1 was significantly overexpressed only in the higher dose of the KP-13-treated group compared to the sham-operated group (*p < 0.05). The gene discussed is CCN2; the disease is chronic kidney disease.